This website uses cookies to give you the best experience. By continuing to use this website you are consenting to cookies being used. You can delete and block cookies from within your browsers settings. For more information please refer to our privacy and cookie policy page.

Continue

Understand | diagnose | change

Whether you are looking to learn more about paediatric musculoskeletal problems, or are involved in the care of children, then PMM and PMM-Nursing will help you change your clinical practice for the better. PMM is free and open to all!

Home
Resources
Key References & Guidelines
NICE guidance on the use of Abatacept, Adalimumab, Etanercept and Tocilizumab for treating Juvenile Idiopathic Arthritis (NICE 2015)

Back

NICE guidance on the use of Abatacept, Adalimumab, Etanercept and Tocilizumab for treating Juvenile Idiopathic Arthritis (NICE 2015)

https://www.nice.org.uk/guidance/ta373